Clinical Trial Update: A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial of intravenous AMB-05X in Tenosynovial Giant Cell Tumor (PVNS) was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pigmented Villonodular Synovitis
• Tenosynovial Giant Cell Tumor

Drugs mentioned

• AMB-05X

Snippet

Sponsor: AmMax Bio, Inc. | Conditions: Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis | Phase 2 | Status: TERMINATED | Results posted: 2024-05-24